Redbiotec

Founded in 2006, Redbiotec is a dairy industry manufacturer based in Schlieren, Switzerland selling ingredients & cultures.

Redbiotec is a private biotech company based in Zurich-Schlieren, Switzerland, founded in 2006 as a spin-off of ETH Zurich. Its work covers two main areas: engineering yeast and bacteria to produce key milk proteins, and developing living medicines and vaccines. The dairy-related activity centres on expressing kappa casein for producers of animal-free milk and other dairy products, with work on glycosylation and phosphorylation of the protein and cell-free manufacturing of genetic materials. The company's CMV vaccine program was acquired by Pfizer in 2015 and it is developing an HSV-2 therapeutic program.